Bicycle Therapeutics (BCYC) Change in Accured Expenses (2018 - 2026)

Bicycle Therapeutics has reported Change in Accured Expenses for 9 years, with the latest figure at -$2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 71.33% year-over-year to -$2.4 million; the trailing twelve-month figure through Mar 2026 stood at $9.9 million (up 44.13% YoY), and the FY2025 full-year result was $4.1 million, down 57.8% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$2.4 million, down from $2.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $11.5 million in Q2 2023, with the low at -$8.2 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged $1.5 million across 5 years, with a median of $1.8 million in 2024.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 2687.8% — and 2023, when it slumped 202.01%.
• Bicycle Therapeutics' Change in Accured Expenses stood at $6.9 million in 2022, then slumped by 153.68% to -$3.7 million in 2023, then soared by 201.63% to $3.7 million in 2024, then sank by 46.61% to $2.0 million in 2025, then plunged by 217.65% to -$2.4 million in 2026.
• The last three Change in Accured Expenses figures came in at -$2.4 million (Q1 2026), $2.0 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.